National Classroom > Webinars > PEHSU Grand Rounds February 2018

PEHSU Grand Rounds Webinar

This webinar is part of an ongoing series of educational presentations by experts on issues that focus on current and emerging aspects of pediatric and reproductive environmental health.

Endocrine Disrupting Chemicals and Obesity - February 21, 2018

These presentations focus on the impact of environmental exposures to chemicals on human health at the vulnerable stages of in utero and pediatric development. A number of topics will be included – all of them relevant to questions of exposure and health effects, with consideration of risk reduction. Speakers will include physicians and PhD subject matter experts, as well as individuals with expertise in areas such as home assessment, laboratory analysis, and risk communication.

Learning Objectives

By the end of this module, participants should be able to:

Understand how EDCs can contribute to obesity
Be able to name at least one EDC that may contribute to obesity
Know the obesogen hypothesis

Presenter: Sheela Sathyanarayana, MD, MPH

Sheela Sathyanarayana, MD, MPH

Associate Professor, University of Washington Department of Pediatrics/ Seattle Children’s Research Institute; Attending Physician, Harborview Medical Center, PEHSU; Medical Director, University of Washington Newborn Nursery

Seattle, WA

PEHSU Region 10

Dr. Sathyanarayana is an Associate Professor of Pediatrics and Adjunct Associate Professor of Environmental and Occupational Health Sciences at the University of Washington. She co-directs the US EPA and ATSDR funded University of Washington Pediatric Environmental Health Specialty Unit which provides environmental health based consultations to providers and local/state governmental officials. As a physician scientist, she practices general pediatrics and conducts research focused on endocrine disrupting chemicals, including phthalates and bisphenol A in pregnancy and early childhood. She serves as the center director for The Infant Development and Environment Study which is a multi-center cohort study of phthalate exposures in pregnancy and health outcomes in children. She leads two other NIH studies on genetic polymorphisms and sex steroid hormone concentrations in relation to environmental exposures and childhood health outcomes. In this capacity, she has developed extensive expertise in prenatal/child cohort recruitment, retention, and engagement. In 2013, she was named Outstanding New Investigator within the University of Washington Center for Ecogenetics and Environmental Health. She recently finished serving a 6 year term as chair for the US Environmental Protection Agency’s Children’s Health Protection Advisory Committee and now serves on the National Academies of Sciences Committee on Endocrine Disrupting Chemicals and Low Dose Toxicity. She is the co-PI of the ECHO PATHWAYS study at the University of Washington and Seattle Children’s Research Institute. This study brings together three cohorts at different stages of recruitment/follow-up/analysis. In this manner, it serves as a microcosm for the national ECHO effort to harmonize and prospectively collect data. Dr. Sathyanarayana hopes to be able to represent all the cohorts in order to be able to both capitalize and not over burden studies in order to meet national goals.

Webinar Recording and Materials

Continuing Education

To receive continuing education (CE):

First establish a login with the CDC if you have not already. Click here to access the CDC Training and Continuing Education Online webpage.
Complete the activity
Complete the Evaluation at www.cdc.gov/TCEOnline
Pass the posttest at 80% at www.cdc.gov/TCEOnline (Posttest consists of a mix of five multiple choice and true/false questions.)

FEES: No fees are charged for CDC’s CE activities.

ACCREDITATION STATEMENTS:

CME activities with Joint Providers: This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the Centers for Disease Control and Prevention and the American College of Medical Toxicology. The Centers for Disease Control and Prevention is accredited by the (ACCME^®) to provide medical education for physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Regarding WC2588 - The Centers for Disease Control and Prevention designates this live educational activity for a maximum of 1.0 AMA PRA Category 1 Credits™.

Regarding WD2588 - The Centers for Disease Control and Prevention designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™.

Other Credit types:

CNE: The Centers for Disease Control and Prevention is accredited as a provider of Continuing Nursing Education by the American Nurses Credentialing Center's Commission on Accreditation.This activity provides 1.0 contact hours.
CEU: The Centers for Disease Control and Prevention is authorized by IACET to offer 1.0 CEU's for this program.
CECH: Sponsored by the Centers for Disease Control and Prevention, a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc. This program is designated for Certified Health Education Specialists (CHES) and/or Master Certified Health Education Specialists (MCHES) to receive up to 1.0 total Category I continuing education contact hours. Maximum advanced level continuing education contact hours available are 0. CDC provider number 98614.
For Certified Public Health Professionals (CPH)
CDC is an approved provider of CPH Recertification Credits by the National Board of Public Health Examiners. Effective October 1, 2013, the National Board of Public Health Examiners (NBPHE) accepts continuing education units (CEU) for CPH recertification credits from CDC. Please select CEU as your choice for continuing education when registering for a course on TCEOnline. Learners seeking CPH should use the guidelines provided by the NBPHE for calculating recertification credits. For assistance please contact NBPHE at http://www.NBPHE.org.

DISCLOSURE: In compliance with continuing education requirements, all presenters must disclose any financial or other associations with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters as well as any use of unlabeled product(s) or product(s) under investigational use.

CDC, our planners, presenters, and their spouses/partners wish to disclose they have no financial interests or other relationships with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters with the exception of Charles A. McKay and he wishes to disclose that he is a member of the Scientific Advisory Council, Environmental Health Research Foundation (EHRF). EHRF addresses issues related to biomonitoring, a topic that is also relevant to some of the activities in the Grand Round Series that might be discussed in future sessions. EHRF receives funding from sources that includes industry. Dr. McKay has reviewed and written material for EHRF, that could create a perceived conflict of interest regarding environmental chemical exposure assessment/measurement.

Planning committee discussed conflict of interest with Dr. Charles A. McKay to ensure there is no bias. Content will not include any discussion of the unlabeled use of a product or a product under investigational use. CDC does not accept commercial support.

Disclaimers

This material was supported by the American College of Medical Toxicology (ACMT) and funded (in part) by the cooperative agreement FAIN: U61TS000238-04 from the Agency for Toxic Substances and Disease Registry (ATSDR).

Acknowledgement: The U.S. Environmental Protection Agency (EPA) supports the PEHSU by providing partial funding to ATSDR under Inter-Agency Agreement number DW-75-95877701-4. Neither EPA nor ATSDR endorse the purchase of any commercial products or services mentioned in PEHSU publications.